Genetic findings | Clinical characteristics | Implication of the Variant | Reported families/ affected individuals | Reference | |||
---|---|---|---|---|---|---|---|
Type of the variant | Pathogenic Variant | Zygosity | Localization on the protein | ||||
Missense; de novo | c.518 T > C;p.V173A | H | GC binding domain | ASD | Implication in chromatin modification, FMRP-associated mechanisms and embryonic development | 1/1 | [28] |
Missense | c.842 T > C;p.F281S | H | GC binding domain | SUDEP | Implication in the underlying mechanisms of SUDEP | 1/1 | [29] |
Missense | c.914C > T;p.Y305M | H | Lumenal domain | PS | Possible modifier in the PS | 1/2 | [30] |
Nonsense | c.1365; p.W455X | CH | Lumenal domain | Epilepsy and neurodevelopmental disorders | Implication in the underlying mechanisms of epilepsy and neurodevelopmental disorders | 1/1 | [31] |
Frameshift | c.434_435insAG; p.W146SfsX16a | CH | Lumenal domain | ||||
Missense | c.1412A > G;p.E471G | H | TM domain | Gaucher disease, myoclonic epilepsy, dementia | Possible modifier in the binding dependent mechanisms of LIMP-2 and GC | 1/2 | [32] |
Frameshift | c.350_351delAT; p.Y117CfsX3 | HM | Lumenal domain | Cerabellar ataxia, seizures, myoclonus and dementia reported in general. Detailed patient specific information was NR | Implication in the cerabellar ataxia, seizures, myoclonus and dementia | 1/1 | [33] |
Frameshift | c.1337delG;p.G446VfsX48 | CH | Lumenal domain | Seizures | NR | 1/1 | [34] |
Frameshift | c.434_435insAG;p.W146SfsX16a | CH | Lumenal domain |